Truncation of human dopamine transporter by protease calpain

Neurochemistry International

Volumn 52, Issue 8, 2008, Pages 1436-1441

  Franekova, Veronika ^a   Baliova, Martina ^a   Jursky, Frantisek ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Calpain; Dopamine transporter; RACK1; Receptor of activated protein kinase C

Indexed keywords

AMPHETAMINE; CALPAIN; CALPASTATIN; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; PEPTIDE FRAGMENT; RECEPTOR FOR ACTIVATED C KINASE 1; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; DOPAMINE RELEASE; EMBRYO; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; RAT;

AMINO ACID SEQUENCE; ANIMALS; CALPAIN; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENZYME INHIBITORS; FEMALE; HUMANS; PEPTIDE FRAGMENTS; PROTEIN KINASE C; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, DOPAMINE D2; RECOMBINANT PROTEINS; SERINE; SYNAPTOSOMES; THREONINE;

RATTUS;

EID: 44749086865     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.04.001     Document Type: Article

References (53)

1. Amenta F., Bronzetti E., Cantalamessa F., El-Assouad D., Felici L., Ricci A., and Tayebati S.K. Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes. J. Neuroimmunol. 117 (2001) 133-142
2. Baliova M., Betz H., and Jursky F. Calpain-mediated proteolytic cleavage of the neuronal glycine transporter, GlyT2. J. Neurochem. 88 (2004) 227-232
3. Baliova M., and Jursky F. Calpain sensitive regions in the N-terminal cytoplasmic domains of glycine transporters GlyT1A and GlyT1B. Neurochem. Res. 30 (2005) 1093-1100
4. Bauman A.L., Apparsundaram S., Ramamoorthy S., Wadzinski B.E., Vaughan R.A., and Blakely R.D. Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J. Neurosci. 20 (2000) 7571-7578
5. Binda F., Lute B.J., Dipace C., Blakely R.D., and Galli A. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current. Neuropharmacology 50 (2006) 354-361
6. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., and Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7297-7301
7. Breier A., Su T.-P., Saunders R., Carson R.E., Kolachana B.S., de Bartolomeis A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., and Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 2569-2574
8. Carafoli E., and Molinari M. Calpain: a protease in search of a function?. Biochem. Biophys. Res. Commun. 247 (1998) 193-203
9. Carvelli L., McDonald P.W., Blakely R.D., and Defelice L.J. Dopamine transporters depolarize neurons by a channel mechanism. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 16046-16051
10. Cerruti C., Walther D.M., Kuhar M.J., and Uhl G.R. Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. Brain Res. Mol. Brain Res. 18 (1993) 181-186
11. Ciliax B.J., Heilman C., Demchyshyn L.L., Pristupa Z.B., Ince E., Hersch S.M., Niznik H.B., and Levey A.I. The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci. 15 (1995) 1714-1723
12. Chemuturi N.V., Haraldsson J.E., Prisinzano T., and Donovan M. Role of dopamine transporter (DAT) in dopamine transport across the nasal mucosa. Life Sci. 79 (2006) 1391-1398
13. Crocker S.J., Smith P.D., Jackson-Lewis V., Lamba W.R., Hayley S.P., Grimm E., Callaghan S.M., Slack R.S., Melloni E., Przedborski S., Robertson G.S., Anisman H., Merali Z., and Park D.S. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J. Neurosci. 23 (2003) 4081-4091
14. Dufty B.M., Warner L.R., Hou S.T., Jiang S.X., Gomez-Isla T., Leenhouts K.M., Oxford J.T., Feany M.B., Masliah E., and Rohn T.T. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation. Am. J. Pathol. 170 (2007) 1725-1738
15. Elce J.S., Hegadorn C., Gauthier S., Vince J.W., and Davies P.L. Recombinant calpain II: improved expression system and production of a C105A active site mutant for crystallography. Protein Eng. 8 (1995) 843-848
16. Forsburg S.L., and Sherman D.A. General purpose tagging vectors for fission yeast. Gene 191 (1997) 191-195
17. Frankhauser P., Grimmer Y., Bugert P., Deuschle M., Schmidt M., and Schloss P. Characterization of the neuronal dopamine transporter DAT in human blood platelets. Neurosci. Lett. 399 (2006) 197-201
18. Giros B., el Mestikawy S., Bertrand L., and Caron M.G. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295 (1991) 149-154
19. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
20. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., and Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 9991-9996
21. Herkenham M. Mismatches between neurotransmitter and receptor localizations in brain: observations and implications. Neuroscience 23 (1987) 1-38
22. Higuchi M., Tomioka M., Takano J., Shirotani K., Iwata N., Masumoto H., Maki M., Itohara S., and Saido T.C. Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. J. Biol. Chem. 280 (2005) 15229-15237
23. Ingram S.L., Prasad B.M., and Amara S.G. Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat. Neurosci. 5 (2002) 971-978
24. Jourdi H., Yanagihara T., Martinez U., Bi X., Lynch G., and Baudry M. Effects of positive AMPA receptor modulators on calpain-mediated spectrin degradation in cultured hippocampal slices. Neurochem. Int. 46 (2005) 31-40
25. Jursky F., and Nelson N. Localization of glycine transporter (GLYT2) reveals correlation with the distribution of glycine receptor. J. Neurochem. 64 (1995) 1026-1033
26. Khoshbouei H., Sen N., Guptaroy B., Johnson L., Lund D., Gnegy M.E., Galli A., and Javitch J.A. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol. 2 (2004) 0387-0394
27. Kilty J.E., Lorang D., and Amara S.G. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254 (1991) 578-579
28. Kozak M. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J. Biol. Chem. 266 (1991) 19867-19877
29. Kuhn K., Wellen J., Link N., Maskri L., Lubbert H., and Stichel C.C. The mouse MPTP model: gene expression changes in dopaminergic neurons. Eur. J. Neurosci. 17 (2003) 1-12
30. Lee K.H., Kim M.Y., Kim D.H., and Lee Y.S. Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter. Neurochem. Res. 29 (2004) 1405-1409
31. Lee F.J., Pei L., Moszczynska A., Vukusic B., Fletcher P.J., and Liu F. Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J. 26 (2007) 2127-2136
32. Liu Y., Dore J., and Chen X. Calcium influx through L-type channels generates protein kinase M to induce burst firing of dopamine cells in the rat ventral tegmental area. J. Biol. Chem. 282 (2007) 8594-8603
33. Mabjeesh N.J., and Kanner B.I. Neither amino nor carboxyl termini are required for function of the sodium- and chloride-coupled g-aminobutyric acid transporter from rat brain. J. Biol. Chem. 267 (1992) 2563-2568
34. Mazei-Robinson M.S., and Blakely R.D. ADHD and the dopamine transporter: are there reasons to pay attention?. Hand. Exp. Pharmacol. 175 (2006) 373-415
35. Melikian H.E., and Buckley K.M. Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19 (1999) 7699-7710
36. Merali Z., and Park D.S. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J. Neurosci. 23 (2003) 4081-4091
37. Miranda M., Dionne K.R., Sorkina T., and Sorkin A. Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter. Mol. Biol. Cell 18 (2007) 313-323
38. Mortensen O.V., and Amara S.G. Dynamic regulation of the dopamine transporter. Eur. J. Pharmacol. 479 (2003) 159-170
39. Nirenberg M.J., Vaughan R.A., Uhl G.R., Kuhar M.J., and Pickel V.M. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J. Neurosci. 16 (1996) 436-447
40. Phansuwan-Pujito P., Boontem P., Chetsawang B., Ebadi M., and Govitrapong P. Dopamine transporter immunoreactive terminals in the bovine pineal gland. Neurosci. Lett. 403 (2006) 78-83
41. Ritz M.C., Lamb R.J., Goldberg S.R., and Kuhar M.J. Cocaine receptors on dopamine transporters are related to self administration of cocaine. Science 237 (1987) 1219-1223
42. Schultz W. Multiple dopamine functions at different time courses. Annu. Rev. Neurosci. 30 (2007) 259-288
43. Shih J.C. Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B. Neurotoxicology 25 (2004) 21-30
44. Shimada S., Kitayama S., Lin C.L., Patel A., Nanthakumar E., Gregor P., Kuhar M., and Uhl G. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254 (1991) 576-578
45. Sorkina T., Hoover B.R., Zahniser N.R., and Sorkin A. Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 6 (2005) 157-170
46. Sotnikova T.D., Beaulieu J.-M., Gainetdinov R.R., and Caron M.G. Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter. CNS Neurol. Disorders Drug Targets 5 (2006) 45-56
47. Staszewski R.D., and Yamamoto B.K. Methamphetamine-induced spectrin proteolysis in the rat striatum. J. Neurochem. 96 (2006) 1267-1276
48. Tompa P., Buzder-Lantos P., Tantos A., Farkas A., Szilagyi A., Banoczi Z., Hudecz F., and Friedrich P. On the sequential determinants of calpain cleavage. J. Biol. Chem. 279 (2004) 20775-20785
49. Trifiletti R.R., and Bandele A.N. Antibodies to the calpain-calpastatin complex in patients with Tics, Tourette syndrome, or obsessive-compulsive disorder. Ann. Neurol. 48 (2000) 542
50. Usdin T.B., Mezey E., Chen C., Brownstein M.J., and Hoffman B.J. Cloning of the cocaine-sensitive bovine dopamine transporter. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 11168-11171
51. Wu X., and Gu H.H. Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue. Gene 233 (1999) 163-170
52. Winterer G., and Weinberger D.R. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 27 (2004) 683-690
53. Yurko-Mauro K.A., and Friedman E. Dopamine-stimulated changes in activated calpain I in rat hippocampal slices. J. Neurosci. Res. 43 (1996) 476-481